Exceeding analysts' top- and bottom-line first-quarter 2026 estimates, Nebius posted strong financial results, which ...

Both companies are critical to the AI build-out. But one's growth profile and order book make it the more compelling buy.

Novo Nordisk and Biogen are underpriced and stand to gain from new indications for their blockbuster therapies.

Veradermics develops novel dermatology treatments, targeting both adult and pediatric markets with a research-driven approach ...

Several U.S. business leaders, including Nvidia CEO Jensen Huang, accompanied Trump. Huang believes the Chinese AI chip ...

State Street SPDR Portfolio MSCI Global Stock Market ETF includes U.S. equities while Vanguard Total International Stock ETF ...

This clinical-stage biotech develops targeted therapies for RAS/MAPK pathway-driven cancers, addressing hard-to-treat tumor ...

Plug Power continues to see improvement in its business. However, the stock remains speculative. Let's dig into the company's ...

Oklo aims to achieve criticality by the DOE’s Reactor Pilot Program deadline. A successful test could prove its business ...

SpaceX could be going public as soon as next month at a valuation of $1.75 trillion. SpaceX is targeting to raise $75 billion ...

The other big concern is the expectation for slightly slower growth, as Shopify called for revenue growth in the high-20% ...

Thursday, May 14, 2026 at 8:30 a.m. ET. CALL PARTICIPANTS. Chief Executive Officer — Michael Stein; Chief Financial Officer — ...